Thermal Contrast Assay Nanoparticle Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current lateral flow assays (LFAs) have limited analytical sensitivity, making them less effective for early disease detection at low antigen levels, and existing methods for improving sensitivity, such as microfluidics and biobarcodes, are not yet reliable or cost-effective for point-of-care use.
Innovation Solution
A thermal contrast assay system that uses nanoparticles conjugated to analyte binding molecules, a test region with capture molecules, and a thermal contrast reader with an energy source and sensor to detect and quantify analytes by measuring the heating response to an applied energy signal, enhancing sensitivity and dynamic range.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If lateral flow assay (LFA) is used for rapid disease identification, then the assay is inexpensive, simple, portable and robust, but the analytical sensitivity is limited to mM to μM range which is significantly less sensitive than other molecular techniques
Solution Approach 1:
The patent changes the detection parameter from optical to thermal by measuring temperature changes instead of optical signals. This allows the simple LFA format to achieve ELISA-level sensitivity (nM to pM range) by detecting the thermal signature of nanoparticle-antigen complexes, resolving the contradiction between operational simplicity and analytical sensitivity.
Solution Approach 2:
The patent replaces the optical detection mechanism with thermal detection. Instead of using optical sensors to detect color changes, the system uses temperature sensors to measure heat generation from nanoparticles, thereby achieving higher sensitivity while maintaining the simplicity of the LFA format.
2Measurement precision
If microfluidics, biobarcodes or enzyme-based assay technologies are used to obtain higher sensitivity in antigen detection, then the detection sensitivity may potentially reach nM to pM range, but these methods are still in the development stage and have not been demonstrated for adoption in a reliable, cost-effective manner
Solution Approach 1:
The patent segments the detection function by using nanoparticles as discrete thermal signatures that can be individually detected. Each nanoparticle-antigen complex acts as an independent thermal source, allowing sensitive detection through cumulative thermal signal measurement while maintaining the robustness of the LFA format for point-of-care use.
Solution Approach 2:
The patent introduces nanoparticles as an intermediary that converts the binding event into a measurable thermal signal. The nanoparticles serve as a bridge between the antigen-antibody interaction and the temperature sensor, enabling high-sensitivity detection while maintaining simplicity and reliability for point-of-care applications.
3Measurement precision
If thermal contrast detection with nanoparticles is used, then the analytical sensitivity can be significantly improved with potential 10,000-fold improvement over visual detection methods, but the device complexity increases with energy source and thermal sensor requirements
Solution Approach 1:
The patent adapts the colorimetric LFA format for thermal detection by using nanoparticles that generate detectable thermal signatures upon binding. The visual test strip format is retained, but the readout mechanism is enhanced with thermal sensors, achieving high sensitivity without completely redesigning the assay format.
Solution Approach 2:
The patent creates a multi-functional reader system that can potentially accommodate different detection modes (optical and thermal) using the same basic LFA strip format. This universality allows the system to achieve high sensitivity through thermal detection while maintaining the simplicity and robustness of the original LFA design for various applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The thermal contrast system significantly improves analytical sensitivity, enabling earlier disease detection and quantification, with a potential 10,000-fold improvement over visual detection methods, and is suitable for resource-limited settings and point-of-care facilities.
Implementation Method 1
the enhanced photothermal signature of metal nanoparticles have been utilized
Data Source
Figure 1
Figure 2A
Figure 2B
AI summary
Assays used in conjunction with a thermal contrast reader are disclosed. In the assay, the test strip includes materials that can develop a thermal response if a target analyte is present in a sample. The thermal contrast reader includes housing having an opening to receive the test strip at a test location, an energy source directed at the test location and a heat sensor directed at the test location. The heat sensor is configured to sense heating of the test strip upon activation of the heat source at the test location, if the target analyte is present in the sample. The heat sensor can provide sensor output using diagnostic circuitry coupled to the sensor output and configured to provide a diagnostic output. The diagnostic output can indicate the diagnostic condition of the patient as a function of the sensor output. The present disclosure also includes methods of detecting target analytes and kits comprising lateral flow assays and thermal contrast reader.